SCAI SHOCK 2022
SCAI SHOCK 2022
Advertisement
CardioNerdsSCAI SHOCK 2022 | November 1, 2022
In the FlowTriever for Acute Massive Pulmonary Embolism (FLAME) study, researchers aimed to assess treatment outcomes of ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
Cardiogenic shock is challenging to treat, and traditionally results in poor outcomes. Therefore, it is critical to ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The Incorporating SuperSaturated Oxygen in Shock (ISO-Shock) study assessed the safety and efficacy of TherOx ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The Cardiogenic Shock Working Group (CSWG) is a multicenter registry developed to collate clinical data on shock ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
Cardiogenic shock treatment in the United States has changed as novel therapies and innovative devices have emerged in ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The National Cardiogenic Shock Initiative (NCSI) aims to bring together centers from across the U.S. that specialize in ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The RECOVER IV trial is a two-arm study that seeks to analyze whether percutaneous coronary intervention (PCI) with ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The CAPITAL DOREMI 2 study is a multi-centre, double-blind, randomized controlled trial which assessed the safety and ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The recent DanGer Shock trial sought to assess if the use of left ventricular mechanical circulatory support using ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The Pulmonary Artery Catheter in Cardiogenic Shock Trial (PACCS) was conducted to analyze if early invasive hemodynamic ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
Despite advances in treatment, cardiogenic shock (CS) outcomes remain dire. As such, researchers initiated the ...
CardioNerdsSCAI SHOCK 2022 | July 10, 2025
The American Heart Association (AHA) recently created the Cardiogenic Shock Registry to enhance the quality of care and ...
Advertisement